Genmab
Search results
Innovating for Patients and Society. Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.
Grifols, S.A. (Catalan: [ˈɡɾifuls]) is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma –based products, a field in which it is the European leader and largest worldwide, [ 3 ] [ 4 ] the company also supplies devices , instruments, and reagents for clinical testing ...
An experienced and trusted partner to blood banks and hospital transfusion centers, Grifols is a global leader in transfusion medicine and a pioneer in disease detection. Learn how our diagnostic solutions can help improve and simplify your laboratory operations.
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines...
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world. The company develops, produces, and provides innovative healthcare services and solutions in more than 110 countries.
Understanding Grifols. We address the needs of thousands of patients. Joining forces with Biotest. Our global footprint. Our business model creates value. Sustainability and human rights. Grifols’ value chain. Donors and patients. Innovation at Grifols
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world. The company develops, produces, and provides innovative healthcare services and solutions in more than 110 countries.
Grifols is a leading global healthcare company founded in Barcelona in 1909 that develops and provides plasma-derived medicines and other innovative biopharmaceuticals and diagnostic solutions to enable millions of patients around the world to lead more productive lives.
Mar 8, 2024 · Shares of Spanish drugmaker Grifols rose more than 16% on Friday morning after it said auditor KPMG approved its 2023 results with an unqualified opinion, without modifying the profit and debt ...
6 days ago · Grifols is focused on treating conditions across a broad range of therapeutic areas: neurology, immunology, hepatology and intensive care, pulmonology, hematology and infectious diseases. A pioneer in the plasma industry, we have the largest network of donation centers in the world, with more than 390 centers across North America ...
